Found 8 matching trials
Opicapone Treatment Initiation Open-Label Study N/A This is an observational study to describe the treatment patterns and clini...
Show More Location
Neurocrine clinical site
Learn More & Join Trial
Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC) PHASE1 This study evaluates the bioavailability and bioequivalence between two act...
Show More Location
Simbec Research Ltd
Learn More & Join Trial
A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD PHASE4 A Study to evaluate the add-on efficacy and safety of opicapone 50 mg or an...
Show More Location
Hallym University Sacred Heart Hospital
Learn More & Join Trial
Safety and Effectiveness of Opicapone Plus Standard of Care in Elderly Patients With Parkinson's Disease N/A The purpose of this study is to describe the safety and efficacy of opicapo...
Show More Location
Norfolk&Norwich University Hospitals
Learn More & Join Trial
Relative Bioavailability and Bioequivalence of Opicapone PHASE1 the purpose assess the relative bioavailability and bioequivalence of two a...
Show More Location
Covance Clinical Research
Learn More & Join Trial
Effect of Food on Opicapone PHASE1 The purpose of this study is to investigate the effect of food on the catec...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Opicapone in Clinical Practice PHASE4 The purpose of this study is to evaluate the change in subject's condition ...
Show More Location
University Hospital Carl Gustav Carus at the TU Dresden, Neurological University Clinic
Learn More & Join Trial
Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone PHASE1 The purpose of this study is to evaluate the bioavailability and the bioequ...
Show More Learn More & Join Trial